Montalvo Fernando A MD is categorized under Electrolysis and Epilatory Services in Miami, FL and active since 1984.
Montalvo Fernando A MD was established in 1984, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Electrolysis and Epilatory Services business, which does work in the B2C market, and is classified as a Electrolysis and Epilatory Services, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Fernando Montalvo at the company’s single location by writing to 2901 Sw 8th St # 107, Miami, Florida FL 33135 or by phoning (305) 541-4833. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Montalvo Fernando A MD |
| Contact Person: | Fernando Montalvo |
| Address: | 2901 Sw 8th St # 107, Miami, Florida 33135 |
| Phone Number: | (305) 541-4833 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1984 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Electrolysis and Epilatory Services |
| SIC Code: | 7231 |
| NAICS Code: | 6211110 |
| Share This Business: |
Montalvo Fernando A MD was started in 1984 to provide professional Electrolysis and Epilatory Services under the SIC code 7231 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Fernando Montalvo for inquiries that concern Montalvo Fernando A MD by calling the company number (305) 541-4833, as your correspondence is most welcome. Additionally, the physical location of the single location of Montalvo Fernando A MD can be found at the coordinates 25.765145,-80.241633 as well as the street address 2901 Sw 8th St # 107 in Miami, Florida 33135.
For its online presence, you may visit Montalvo Fernando A MD’s website at and engage with its social media outlets through on Twitter and on Facebook.